Tsugumine Shu
Director/Board Member at I'ROM GROUP CO., LTD.
Net worth: 510 685 $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Hiroaki Inukai | M | 58 | 14 years | |
Toyotaka Mori | M | 65 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 12 years |
Kiyoshi Watanabe | M | 66 | 19 years | |
Masaaki Matsushima | M | 59 | 26 years | |
Shuichi Kojima | M | 55 | 19 years | |
Toshiya Hara | M | 54 | 27 years | |
Takeshi Takahashi | M | 53 | 6 years | |
Toyoji Maeda | M | 63 | 3 years | |
Atsushi Tsubaki | M | 64 | 5 years | |
Hidetsugu Kuwahara | M | 55 | 27 years | |
Minoriko Komaki | F | 67 | 6 years | |
Hidetsugu Sasaki | M | 73 | 14 years | |
Hiroyuki Fukase | M | 63 | 7 years | |
Chikaaki Kato | M | 64 | 11 years | |
Makoto Inoue | M | - |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 20 years |
Naomi Ninagawa | F | - | 27 years | |
Kiyomi Kindaichi | F | 61 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 15 years |
Kunikatsu Shirahata | M | - |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 20 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Masaharu Inoue | M | 62 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Yohei Tanida | M | 62 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Masayoshi Kikuoka | M | 63 | - | |
Shiro Toba | M | 57 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Keiji Hasumi | M | 66 |
Tokyo University of Agriculture & Technology
| 3 years |
Hayato Narisoko | M | 60 |
Tokyo University of Agriculture & Technology
| 4 years |
Shitotomo Yamauchi | M | 91 | - | |
Tsumoru Miyano | M | 58 |
Tokyo University of Agriculture & Technology
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
Japan | 26 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tsugumine Shu
- Personal Network